Evidence map›Paper›PMID 30552094›Full record

ArticleEMBO molecular medicine2019

RGS9-2 rescues dopamine D2 receptor levels and signaling in

Paola Bonsi, Giulia Ponterio, Valentina Vanni, Annalisa Tassone, Giuseppe Sciamanna, Sara Migliarini, Giuseppina Martella, Maria Meringolo, Benjamin Dehay, Evelyne Doudnikoff and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in EMBO molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05855577 (-Clinical Efficacy of Pharmacological Treatments Targeting Energy Metabolism, Evaluated by Gait Analysis, on Motor Function in Parkinson's Disease Patients), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05855577 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

-Clinical Efficacy of Pharmacological Treatments Targeting Energy Metabolism, Evaluated by Gait Analysis, on Motor Function in Parkinson's Disease Patients

TypeinterventionalSponsorI.R.C.C.S. Fondazione Santa LuciaRan2023 to 2026Enrolled50ConditionsParkinson Disease, Gait Analysis, Therapy, Directly Observed, Metabolic DiseaseArmsTerazosin
3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  11. Article
  12. Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice.International journal of molecular sciences · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Paola BonsiLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy p.bonsi@hsantalucia.it pisani@uniroma2.it.ORCID 0000-0001-5940-9028
Giulia PonterioLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Valentina VanniLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Annalisa TassoneLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Giuseppe SciamannaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Sara MigliariniUnit of Cell and Developmental Biology, Department of Biology, University of Pisa, Pisa, Italy.
Giuseppina MartellaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Maria MeringoloLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Benjamin DehayUniversité de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.ORCID 0000-0003-1723-9045
Evelyne DoudnikoffUniversité de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.
Venetia ZachariouDepartment of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rose E GoodchildDepartment of Neurosciences, VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium.ORCID 0000-0002-4524-5728
Nicola B MercuriLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
Marcello D'AmelioLaboratory Molecular Neurosciences, IRCCS Fondazione Santa Lucia, Rome, Italy.
Massimo PasqualettiUnit of Cell and Developmental Biology, Department of Biology, University of Pisa, Pisa, Italy.
Erwan BezardUniversité de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.ORCID 0000-0002-0410-4638
Antonio PisaniLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy p.bonsi@hsantalucia.it pisani@uniroma2.it.ORCID 0000-0002-8432-594X

Funding

REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELSP50MH096890 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALLIS, CHARLES DAVID · 2012 to 2021
$20.2M
Transcription Factors in Stimulant and Opioid ActionP01DA047233 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Anne Schaefer · 2019 to 2026
$16.5M
Cellular Mechanisms of Antidepressant Drug Actions in Neuropathic Pain ModelsR01NS086444 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZACHARIOU, VENETIA · 2014 to 2023
$4.4M
Targeting HDAC6 for the treatment of neuropathic painR21NS098264 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZACHARIOU, VENETIA · 2017 to 2018
$466k
NIDA NIH HHS P01 DA047233NIMH NIH HHS P50 MH096890NINDS NIH HHS R01 NS086444NINDS NIH HHS R21 NS098264
6 · The paper itself

Abstract

Dopamine D2 receptor signaling is central for striatal function and movement, while abnormal activity is associated with neurological disorders including the severe early-onset

Indexed as

Signal TransductionAnimalsCorpus StriatumDisease Models, AnimalDystonia Musculorum DeformansGene ExpressionGene Knockdown TechniquesMice, Inbred C57BLMicrofilament ProteinsMolecular ChaperonesNerve Tissue ProteinsNeurabinsReceptors, Dopamine D2RGS ProteinsDRD2 protein, mouseDyt1 protein, mouseMicrofilament ProteinsMolecular ChaperonesNerve Tissue ProteinsNeurabinsReceptors, Dopamine D2regulator of g-protein signaling 9RGS Proteinsbeta‐arrestinlysosomal degradationstriatum

Identifiers

PMID30552094
PMCPMC6328939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.